[ Price : $8.95]
The Center for Reproductive Rights says it will reopen a 2005 lawsuit against FDA for maintaining unnecessary age restrictions on ...[ Price : $8.95]
FDA releases safety labeling changes approved in November for 48 drug products, including a new Warning and Precaution for 11 HIV/...[ Price : $8.95]
Repros Therapeutics says it met with CDER Divisions of Urologic and Endocrinologic Products to gain input on designing a Phase 3 t...[ Price : $8.95]
ViroPharma says FDA approval of a sNDA for new labeling information for its Vancocin meets agency requirements for three years of ...[ Price : $8.95]
Salix Pharmaceuticals submits an NDA to FDA for crofelemer, indicated for treating HIV-associated diarrhea.[ Price : $8.95]
FDA approves Dakos HER2 CISH pharmDx Kit as an aid in assessing breast cancer patients for whom Herceptin is being considered.[ Price : $8.95]
FDA Webview editor Jim Dickinson reviews FDAs opaque relationships with HHS as shown in the aftermath of the Sebelius Plan B decis...[ Price : $8.95]
FDA says that conflicting results in new studies make it premature to reach a conclusion about a possible link between SSRI antide...